Contact Us | Print Page | Sign In | Register
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Industry News for MS (INforMS)
Thursday, October 11, 2018
CMSC InforMS: TG Therapeutics, Inc. Announces Final Phase 2 MS Data Presentation at ECTRIMS »
Annualized Relapse Rate (ARR) of 0.07 observed for all patients on Phase 2 trial   ECTRIMS data review conf...
Wednesday, September 5, 2018
CMSC INforMS: Researchers Identify New Subtype of Multiple Sclerosis »
Researchers have discovered a new subtype of multiple sclerosis (MS), providing a better understanding of the disease and...
Wednesday, August 29, 2018
CMSC INforMS: MRI Tests May Help Doctors Predict MS Progression in Patients »
Researchers may have figured out how to use information from these imaging tests to determine what type of multiple sclero...
Thursday, August 9, 2018   (0 Comments - view/add)
CMSC INforMS: Researchers Have a New Theory About What May Cause Multiple Sclerosis »
When the following headline in the Australian newspaper the Herald Sun caught my eye recently, I was cautiously intrig...
Monday, July 30, 2018   (0 Comments - view/add)
CMSC INFORMS: FDA Accepts File for Cladribine Tablets as Potential Tx for Relapsing Forms of MS »
PDF   ROCKLAND, Mass., July 30, 2018 – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Ger...

CMSC Outreach
Friday, September 28, 2018   (0 Comments - view/add)
OUR CONDOLENCES TO THE FAMILY OF NICOLA "NICKI" WARD-ABEL, RGN, BSc (Hons), MSCN »
It is with a heavy heart that IOMSN announces the passing of Nicola "Nicki" Ward-Abel. Nicki was a  founding member...
Monday, August 13, 2018
CMSC Outreach: Call for Test Sites: Using Patient-Reported Outcomes to Drive Multiple Sclerosis Care »
Researchers at Northwestern University are seeking volunteers to participate in the pilot testing of a new quality measu...
Wednesday, April 18, 2018
CMSC Outreach: Imagerywork »
Dr. Miriam Franco , PSY.D, MSCS, has developed a new APP that includes a separate page for Guided Imagery for MS, Improvi...
Tuesday, February 6, 2018
CMSC Outreach: Caregivers Bill Supports Patients with Multiple Sclerosis »
President Donald Trump recently signed the Recognize, Assist, Include, Support, and Engage (RAISE) Family Caregivers Act (...
Wednesday, June 28, 2017   (0 Comments - view/add)
CMSC Outreach: IJMSC Wins 2017 APEX Award »
The  International Journal of MS Care  has received an Award of Excellence in the APEX 2017 Awards for Publicati...

New from our Partners
Friday, October 12, 2018
New from our Partners: Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy, »
Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy, Evobrutinib in RMS   Fir...
Wednesday, October 10, 2018
News from our Partners: Novartis announces FDA filing acceptance of siponimod (BAF312) »
Novartis announces FDA filing acceptance of siponimod (BAF312), the first and only oral drug shown to delay disability pro...
Wednesday, October 10, 2018
News from our Partners: Press Release - New Efficacy and Safety Data on MS Portfolio to be Presented »
New Efficacy and Safety Data on MS Portfolio to be Presented at ECTRIMS 2018   Late-breaking Phase I...
Wednesday, October 10, 2018
News from our Partners: Press Release - Ocrevus data show early initiation reduces progression »
PRESS RELEASE: OCREVUS (OCRELIZUMAB) DATA SHOW EARLY INITIATION OF TREATMENT REDUCES DISABILITY PROGRESSION OVER FIVE YEAR...
Wednesday, September 12, 2018   (0 Comments - view/add)
News from our Partners: Novartis announces PARADIGMS study demonstrating benefit of Gilenya® »
Novartis announces NEJM publication of landmark PARADIGMS study demonstrating significant benefit of Gilenya® in children...

The Consortium of Multiple Sclerosis Centers

3 University Plaza Drive, Suite 116 Hackensack, NJ 07601

Tel: 201.487.1050 | Fax: 862.772.7275

info@mscare.org